Accession Number: | 0001140361-22-012919 |
Date: | 2022-03-31 |
Issuer: | PYXIS ONCOLOGY, INC. (PYXS) |
Original Submission Date: |
CIVIK THOMAS
C/O PYXIS ONCOLOGY, INC.
35 CAMBRIDGEPARK DRIVE
CAMBRIDGE, MA 02140
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-03-31 | A | 66,831 | a | $0.00 | 66,831 | direct | ||
COMMON STOCK | 2022-03-31 | 0 | $0.00 | 15,700 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date. |
f2 | these shares are held directly by the civik family trust, a revocable trust for which the reporting person and his spouse are the grantors. |